Management holds a conference call to discuss lifileucel TIL therapy and the emerging melanoma treatment landscape on June 26 at 5 pm. Webcast Link
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on IOVA:
- Iovance Biotherapeutics to host conference call
- Iovance to host roundtable with KOL to discuss melanoma treatments
- Iovance Biotherapeutics to Host Virtual Roundtable with Key Opinion Leaders to Discuss Melanoma Treatment Landscape
- Iovance Biotherapeutics files automatic mixed securities shelf
- Iovance announces first patient randomized in Phase 3 TILVANCE-301 trial